For decades, scientists across the globe have investigated methods to accurately measure drug permeability across the blood-brain barrier, a compact layer of cells that protect the brain from ...

A new generative AI model rapidly generates diverse antimicrobial peptide structures for screening against ...

Oxford Drug Design, the Oxford-based AI drug discovery company, has announced further in vivo validation for its first-in-class cancer treatment approach. The company is developing novel treatments ...

Bioprinting offers a host of benefits that researchers continue to explore. It utilizes a combination of living cells, bio-inks, and 3D printing methods to create complex structures like organs or ...

The successful and safe delivery of therapeutics relies on understanding how easily drugs can pass through biological barriers which protect cells.

Hydrogels are polymeric materials with three-dimensional network structures containing large amounts of water. They serve as sustained-release drug delivery systems as they can encapsulate various ...

Sygnature Discovery has appointed Fraser McIntosh as Vice President, In Vivo Pharmacology. Fraser will lead the company’s in vivo drug discovery operations worldwide.

United Kingdom, 15 th January 2025: Oxford Drug Design, the Oxford-based AI drug discovery company, has today announced additional in vivo validation for its first-in-class approach against cancer as ...